ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,470Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 623

$776K Total Retail Price of All Prescriptions

Rank: 12 out of 623

533 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,960 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 334 290 1 5
AMLODIPINE BESYLATE 320 289 2 3
METFORMIN HCL 306 233 3 6
LOVASTATIN 304 207 4 25
TRAMADOL HCL 297 261 5 15
LEVOTHYROXINE SODIUM 292 252 6 4
OMEPRAZOLE 259 195 7 7
LISINOPRIL 238 171 8 1
METOPROLOL TARTRATE 202 157 9 9
POTASSIUM CHLORIDE 195 179 10 24
HYDROCODONE-ACETAMINOPHEN 192 121 S3 11 17
SIMVASTATIN 189 141 12 2
ATORVASTATIN CALCIUM 161 125 13 10
GABAPENTIN 131 72 14 18
RANITIDINE HCL 119 79 15 23
TRICOR 114 93 16 105
ALENDRONATE SODIUM 109 95 17 37
CLOTRIMAZOLE 108 108 18 173
CRESTOR 106 93 19 28
LANTUS 106 62 19 41
ESCITALOPRAM OXALATE 104 81 21 60
AZITHROMYCIN 103 62 22 45
METOPROLOL SUCCINATE 102 85 23 13
ATENOLOL 99 47 24 12
HYDROCHLOROTHIAZIDE 96 84 25 8
TAMSULOSIN HCL 96 75 25 35
CLOPIDOGREL 94 74 27 34
LEVOFLOXACIN 92 72 28 72
POLYETHYLENE GLYCOL 3350 91 76 29 53
PLAVIX 90 69 30 46
JANUVIA 90 74 30 87
ALBUTEROL SULFATE 90 88 30 69
DONEPEZIL HCL 87 87 33 27
VYTORIN 84 77 34 171
PREDNISONE 82 57 35 40
ZETIA 79 59 36 99
IBUPROFEN 77 44 37 68
FLUTICASONE PROPIONATE 75 30 38 29
CYCLOBENZAPRINE HCL 74 34 R 39 65
CITALOPRAM HBR 72 64 40 21
NEXIUM 72 59 40 43
WARFARIN SODIUM 72 55 40 14
LYRICA 71 63 43 86
ACTOS 70 60 44 128
GEMFIBROZIL 70 42 44 110
SERTRALINE HCL 68 43 46 20
ROPINIROLE HCL 68 58 46 111
TRAZODONE HCL 66 61 48 36
NOVOLOG 65 44 49 75
ADVAIR DISKUS 60 40 50 39
PANTOPRAZOLE SODIUM 58 49 51 26
LACTULOSE 58 58 51 67
CIPROFLOXACIN HCL 58 46 51 61
DIOVAN 57 40 54 48
PROMETHAZINE HCL 56 45 R 55 139
NYSTATIN 56 51 55 141
SUBOXONE 55 0 57 85
QUETIAPINE FUMARATE 54 46 58 51
CARVEDILOL 51 34 59 32
OXYBUTYNIN CHLORIDE 50 46 60 134
ENALAPRIL MALEATE 50 34 60 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.